ARCHIVES

FDA Breakthrough Designation Granted to Pfizer’s Palbociclib

This article is from The Cancer Letter archive.

Vol. 36 No. 4 | April 26, 2013

Download PDF Visit The Full Archive

Related Articles

PET Response Can Predict Increased Survival In Patients

April 27, 2012

Conversation with The Cancer Letter: IU’s Loehrer Discusses “Business Decision” To Close Bloomington Proton Beam Center

October 17, 2014

House Members Express Support for Cancer Program

September 12, 1980

Cohen Directs UK’s Markey Cancer Center; Matrisian Named Chairman, DOD Panel.

September 8, 2000

In Brief: David Tweardy named head of internal medicine at MD Anderson

September 19, 2014

Brain Gliomas Progress When Gene Function Is Lost

April 25, 2003